We are live on ! Find out more
AVNS icon

Avanos Medical

317 hedge funds and large institutions have $1.98B invested in Avanos Medical in 2019 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 79 increasing their positions, 99 reducing their positions, and 54 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,918% more call options, than puts

Call options by funds: $2.25M | Put options by funds: $56K

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

3% more capital invested

Capital invested by funds: $1.93B → $1.98B (+$52.2M)

0.39% more ownership

Funds ownership: 95.08%95.47% (+0.39%)

6% less funds holding

Funds holding: 338317 (-21)

20% less repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 99

28% less first-time investments, than exits

New positions opened: 39 | Existing positions closed: 54

Holders
317
Holders Change
-21
Holders Change %
-6.21%
% of All Funds
6.89%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
39
Increased
79
Reduced
99
Closed
54
Calls
$2.25M
Puts
$56K
Net Calls
+$2.19M
Net Calls Change
-$2.35M
Name Holding Trade Value Shares
Change
Change in
Stake
GT
301
Glenmede Trust
Pennsylvania
$415 +$36.4K +851 +10%
CCM
302
Channing Capital Management
Illinois
-$18.1M -424,782 Closed
Millennium Management
303
Millennium Management
New York
-$10.4M -242,820 Closed
EGM
304
Engineers Gate Manager
New York
-$2.72M -63,735 Closed
MCC
305
Malaga Cove Capital
California
-$2.23M -52,276 Closed
GAM
306
Gotham Asset Management
New York
-$2.16M -50,701 Closed
CM
307
Caption Management
Oklahoma
-$1.32M -31,000 Closed
Voloridge Investment Management
308
Voloridge Investment Management
Florida
-$858K -20,105 Closed
Los Angeles Capital Management
309
Los Angeles Capital Management
California
-$686K -16,065 Closed
LPT
310
Legacy Private Trust
Wisconsin
-$618K -14,487 Closed
JG
311
Jefferies Group
New York
-$389K -9,123 Closed
AQR Capital Management
312
AQR Capital Management
Connecticut
-$344K -8,126 Closed
KWM
313
Kingsview Wealth Management
Oregon
-$318K -7,455 Closed
SEI Investments
314
SEI Investments
Pennsylvania
-$284K -6,655 Closed
GCP
315
GSA Capital Partners
United Kingdom
-$272K -6,370 Closed
PCMI
316
Paradigm Capital Management Inc
New York
-$263K -6,160 Closed
GKIM
317
GW&K Investment Management
Massachusetts
-$232K -5,431 Closed
Connor, Clark & Lunn Investment Management (CC&L)
318
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
-$230K -5,400 Closed
Wolverine Trading
319
Wolverine Trading
Illinois
-$205K -4,793 Closed
JT
320
Jump Trading
Illinois
-$203K -4,752 Closed
BCM
321
Bayesian Capital Management
New York
-$201K -4,700 Closed
QT
322
Quantbot Technologies
New York
-$92K -2,165 Closed
NSIM
323
North Star Investment Management
Illinois
-$76K -1,776 Closed
Group One Trading
324
Group One Trading
Illinois
-$51K -1,190 Closed
SWM
325
SeaCrest Wealth Management
New York
-$47K -1,099 Closed

AVNS Hedge Fund Activity: Q2 2019 in Review

317 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q2 2019, worth a combined $1.98B — up 2.7% from $1.93B a quarter earlier.

Sellers outnumbered buyers: 54 funds closed out of AVNS and 39 opened new positions — a net loss of 15 holders — while 99 trimmed existing stakes and 79 added.

The largest buyer was RGM Capital, adding an estimated $30.3M. The largest seller was Wells Fargo, cutting an estimated $24.1M.

  • 317 institutional investors held Avanos Medical (AVNS) as of Q2 2019, down from 338 in Q1 2019.
  • Funds reported $1.98B of Avanos Medical stock for Q2 2019, up 2.7% quarter-over-quarter.
  • 39 funds opened new Avanos Medical positions in Q2 2019 and 54 closed out, a net change of -15 holders.
  • The largest Avanos Medical buyer in Q2 2019 was RGM Capital, an estimated $30.3M added.
  • The largest Avanos Medical seller in Q2 2019 was Wells Fargo, an estimated $24.1M sold.

Based on aggregated 13F filings for Q2 2019.